Are events after endotoxemia related to circulating phospholipase A2? 1994

A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115.

OBJECTIVE The authors sought to determine whether the signs and symptoms of endotoxemia were related to the endotoxin-stimulated increase in circulating phospholipase A2 (PLA2) activity. BACKGROUND Because hypotension and pulmonary injury have been associated with elevated PLA2 activity in septic shock and PLA2 levels are reduced with the administration of glucocorticoids, the PLA2 response to endotoxin was investigated in volunteers pretreated with and without hydrocortisone. METHODS Carefully screened human subjects were studied under four conditions: (1) saline, (2) hydrocortisone, (3) endotoxin, and (4) hydrocortisone administration before endotoxin exposure. Pulse rate, blood pressure, temperature, and symptoms of endotoxemia were serially measured. Plasma for tumor necrosis factor concentrations and PLA2 activity was obtained. RESULTS After lipopolysaccharide, pulse rate and tumor necrosis factor concentrations rose at 1 to 2 hours; temperature increased maximally at 4 hours. PLA2 activity reached peak levels at 24 hours. With hydrocortisone pretreatment, a 50% reduction in the concentrations of tumor necrosis factor and PLA2 occurred. Significant correlations between other variables and PLA2 activity were not observed. The enzyme identified by monoclonal antibody was the secreted nonpancreatic PLA2 (SNP-PLA2). CONCLUSIONS The results of this study suggest that elevations in circulating SNP-PLA2 activity and systemic events associated with intravenous endotoxin administration are unrelated.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014115 Toxemia A condition produced by the presence of toxins or other harmful substances in the BLOOD. Toxemias
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D054467 Phospholipases A2 Phospholipases that hydrolyze the acyl group attached to the 2-position of PHOSPHOGLYCERIDES. Lecithinase A2,Phospholipase A2

Related Publications

A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
April 2022, Journal of the European Academy of Dermatology and Venereology : JEADV,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
November 1987, Surgery,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
October 2005, Journal of the American College of Cardiology,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
April 2002, The Journal of biological chemistry,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
July 1995, The Journal of infectious diseases,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
August 2004, Biological & pharmaceutical bulletin,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
April 2019, Journal of nephrology,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
February 2012, Circulation,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
February 1998, Annals of surgery,
A A Santos, and J L Browning, and M R Scheltinga, and E A Lynch, and E F Brown, and P Lawton, and E Chambers, and I Dougas, and C D Benjamin, and C A Dinarello
March 1993, Glia,
Copied contents to your clipboard!